Finnish Centre for Evidence-Based Orthopaedics, University of Helsinki, Helsinki, Finland; Department of Orthopaedics and Traumatology, Helsinki University Hospital, Helsinki, Finland.
Institute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, Australia.
Osteoarthritis Cartilage. 2024 Oct;32(10):1184-1196. doi: 10.1016/j.joca.2024.06.001. Epub 2024 Jun 12.
The primary objective was to determine the population prevalence of glenohumeral joint imaging abnormalities in asymptomatic adults.
We systematically reviewed studies reporting the prevalence of X-ray, ultrasound (US), computed tomography, and magnetic resonance imaging (MRI) abnormalities in adults without shoulder symptoms (PROSPERO registration number CRD42018090041). This report presents the glenohumeral joint imaging findings. We searched Ovid MEDLINE, Embase, CINAHL and Web of Science from inception to June 2023 and assessed risk of bias using a tool designed for prevalence studies. The primary analysis was planned for the general population. The certainty of evidence was assessed using a modified Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) for prognostic studies.
Thirty-five studies (4 X-ray, 10 US, 20 MRI, 1 X-ray and MRI) reported useable prevalence data. Two studies were population-based (846 shoulders), 15 studies included miscellaneous study populations (1715 shoulders) and 18 included athletes (727 shoulders). All were judged to be at high risk of bias. Clinical diversity precluded pooling. Population prevalence of glenohumeral osteoarthritis ranged from 15% to 75% (2 studies, 846 shoulders, 1 X-ray, 1 X-ray and MRI; low certainty evidence). Prevalence of labral abnormalities, humeral head cysts and long head of biceps tendon abnormalities were 20%, 5%, 30% respectively (1 study, 20 shoulders, X-ray and MRI; very low certainty evidence).
The population-based prevalence of glenohumeral joint imaging abnormalities in asymptomatic individuals remains uncertain, but may range between 30% and 75%. Better estimates are needed to inform best evidence-based management of people with shoulder pain.
主要目的是确定无症状成年人盂肱关节影像学异常的人群患病率。
我们系统地回顾了报告成人无肩部症状(PROSPERO 注册号 CRD42018090041)X 线、超声(US)、计算机断层扫描和磁共振成像(MRI)异常患病率的研究。本报告介绍了盂肱关节影像学发现。我们从建库到 2023 年 6 月在 Ovid MEDLINE、Embase、CINAHL 和 Web of Science 进行了检索,并使用专为患病率研究设计的工具评估了偏倚风险。主要分析计划针对一般人群进行。使用改良的推荐、评估、制定和评估(GRADE)对预后研究的证据进行评估。
35 项研究(4 项 X 线、10 项 US、20 项 MRI、1 项 X 线和 MRI)报告了可用的患病率数据。有 2 项研究为基于人群的研究(846 个肩),15 项研究包括各种研究人群(1715 个肩),18 项研究包括运动员(727 个肩)。所有研究均被认为存在高偏倚风险。由于临床多样性,无法进行汇总。盂肱骨性关节炎的人群患病率为 15%至 75%(2 项研究,846 个肩,1 项 X 线,1 项 X 线和 MRI;低确定性证据)。盂唇异常、肱骨头囊肿和肱二头肌长头腱异常的患病率分别为 20%、5%、30%(1 项研究,20 个肩,X 线和 MRI;极低确定性证据)。
无症状个体盂肱关节影像学异常的人群患病率仍不确定,但可能在 30%至 75%之间。需要更好的估计值来为肩部疼痛患者的最佳循证管理提供信息。